Schwartz C, Fast D, Knight R Poppers, queer sex and a Canadian crackdown: examining the experiences of alkyl nitrite use among young sexual minority men Int J Drug Policy PubMed

Ickowicz S, Grant C, Nosova E, Boyd J, Brar R, Milloy MJ, Hayashi K, Nolan S Factors associated with the use of supervised consumption facilities among women who inject drugs in a Canadian setting J Addict Med PubMed

Dahlby L, Kerr T PTSD and opioid use: implications for intervention and policy Subst Abuse Treat Prev Policy PubMed

Ickowicz S, Brar R, Nolan S Case study: naltrexone for the treatment of nitrous oxide use J Addict Med PubMed

Kennedy MC, Hayashi K, Milloy MJ, Boyd J, Wood E, Kerr T Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: a gender-based analysis Int J Drug Policy PubMed

Mackay L, Ickowicz S, Hayashi K, Abrahams R Rooming-in and loss of child custody: key factors in maternal overdose risk Addiction PubMed

McNeil R, Puri N, Boyd J, Mayer S, Hayashi K, Small W Understanding concurrent stimulant use among people on methadone: a qualitative study Drug Alcohol Rev PubMed

Bach P, Garrod E, Robinson K, Fairbairn N An acute care contingency management program for the treatment of stimulant use disorder: a case report J Addict Med PubMed

Socías ME, Wood E, Dong H, Brar R, Bach P, Murphy SM, Fairbairn N Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): protocol for a non-inferiority randomized clinical trial Contemp Clin Trials PubMed

Caulfield MDG, Brar R, Sutherland C, Nolan S Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach BMJ Case Rep PubMed